
Cigna (CI) Stock Forecast & Price Target
Cigna (CI) Analyst Ratings
Bulls say
Cigna Group is well-positioned to capitalize on the growing healthcare industry, with its strong focus on providing efficient and affordable healthcare solutions. Its diversified business mix, which includes specialty drug capabilities and minimal exposure to government contracts, sets it apart from its peers and provides a strong foundation for long-term growth. The company's recent success in implementing AI technology and its commitment to sustainability also bode well for its future prospects, making it an attractive investment opportunity.
Bears say
Cigna Group is facing a negative outlook due to potential execution risks in managing medical cost trends and network contracting, as well as potential impact from regulatory changes on rebate economics. Additionally, a protracted economic downturn could affect the company's earnings growth trajectory. Although Cigna has taken actions to support its customers, employees, and the medical community during the pandemic, its PBM business may still face challenges and uncertainties. Overall, there is uncertainty surrounding the company's ability to execute in a complex operating environment, which could lead to negative surprises and affect its overall performance.
This aggregate rating is based on analysts' research of Cigna and is not a guaranteed prediction by Public.com or investment advice.
Cigna (CI) Analyst Forecast & Price Prediction
Start investing in Cigna (CI)
Order type
Buy in
Order amount
Est. shares
0 shares